This chapter gives an overview of the origins, chemistry, composition and production of Fluosol-DA (later Fluosol®), and describes preclinical and clinical studies with the emulsion that led to …

The first approved oxygen-carrying blood substitute was a per fluorocarbon -based product called Fluosol -DA-20, manufactured by Green Cross of Japan. It was approved by the Food and …

2024年2月9日 · Fluosol-DA是全氟烃和全氟三丙胺作为主要活性成分，与Pluronic F-68乳化而成的一种血红蛋白替代品。 由日本的Green Cross Corporation和美国加利福尼亚州洛杉矶的Alpha …

Fluosol (20% intravascular perfluorochemical emulsion) is an oxygen-carrying emulsion used to deliver oxygen to ischemic myocardium during percutaneous transluminal coronary …

人造血液，又称氟化碳乳剂 人工血液，英文名Artificial blood；人造血液是一类具有载氧能力，可暂时替代血液部分功能的 液体制剂。 主要用于外伤、医疗手术等所致大出血的治疗，近年来 …

2006年12月31日 · Fluosol was the first injectable oxygen carrier approved by the US FDA for clinical use. As a result, extensive preclinical and clinical data are available for review, and …

We assessed the safety and efficacy of Fluosol-DA as a red-cell substitute in acute anemia. Twenty-three surgical patients with blood loss and religious objections to receiving blood...

We evaluated the safety and efficacy of Fluosol DA-20% (FDA) as a blood substitute in the treatment of severe anemia. Thirty-six patients received either FDA (n = 21) or …

Fluosol-DA是一种含氟的有机化合物，具有以下主要性质： 性质：Fluosol-DA是一种透明无色液体，具有较低的表面张力和高的氧溶解度。 它是一种人工氧载体，可以在体内输送氧气以增加 …

The approval of Fluosol, a fluorocarbon emulsion for oxygenating the myocardium during the transluminal coronary angioplasty procedure, is a landmark in the field of injectable oxygen …